Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models
Akaishi T., Shimazaki A., Tonouchi A., Ueda K., Miyawaki N., Kawazu K.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Preclinical development
-
Affiliations
Research and Development Division, Santen Pharmaceutical Co., Ltd., 4-20 Ofukacho, Kita-ku, Osaka 530-8552, Japan